Isis Pharmaceuticals News
Most Popular Isis Pharmaceuticals Story
Genzyme, Isis solidify collaboration agreement
Genzyme Corp. and Isis Pharmaceuticals Inc. completed their agreement for the cholesterol drug candidate, mipomersen. The two companies have been developing an agreement to work together and Read more...
Latest Headlines
- June 25, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
